Most equity: Leymus Genomics ApS (2017) '389 DKK
Biggest loss: Leymus Genomics ApS (2017) '389 DKK
Inactive
Director (2016-10-01 - 2024-11-28)
Ultimate beneficial owner (2016-10-27 - 2024-11-28) 78.4% ownership (2019-10-16 – 2024-11-28 ) 100% ownership (2016-10-27 – 2019-10-15 ) 78.4% voting rights (2019-10-16 – 2024-11-28 ) 100% voting rights (2016-10-27 – 2019-10-15 )
Legal owner (2016-10-27 - 2019-10-16) 10% ownership (2016-10-27 – 2019-10-16 ) 10% voting rights (2016-10-27 – 2019-10-16 )
Inactive
Legal owner (2017-10-02 - 2025-06-23) 100% ownership (2017-10-02 – 2025-06-23 ) 100% voting rights (2017-10-02 – 2025-06-23 )
Ultimate beneficial owner (2017-10-02 - 2025-06-23) 100% ownership (2017-10-02 – 2025-06-23 ) 100% voting rights (2017-10-02 – 2025-06-23 )
Director (2018-12-21 - 2024-12-06)
Director (2017-10-02 - 2018-11-30)